Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mountain Rosa canina L for treatment of non-alcoholic fatty liver disease
IRCT20100420003760N8Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Feb 2024
- Countries
- 1
01
Overview
Phase 3 trial of rosa canina in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Lorestan University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
rosa canina
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT20100420003760N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100420003760N8.